These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1921166)

  • 1. [Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as the etiologic agent. I. Bacteriology and pathogenesis].
    Tschäpe H; Böhme G
    Kinderarztl Prax; 1991 Jun; 59(6):161-5. PubMed ID: 1921166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as etiological agent. II. Clinical aspects and epidemiology].
    Böhme G; Tschäpe H
    Kinderarztl Prax; 1991; 59(7-8):200-5. PubMed ID: 1921170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
    Arbus GS
    Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The occurrence of Shiga toxin-producing Escherichia coli in humans and animals].
    Heuvelink AE
    Tijdschr Diergeneeskd; 1999 Nov; 124(22):671-8. PubMed ID: 10596399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
    Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
    Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic uremic syndrome associated with entero-hemorrhagic Escherichia coli].
    Takeda T
    Nihon Rinsho; 1993 Jan; 51(1):198-203. PubMed ID: 8433519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli that cause hemolytic uremic syndrome.
    Cleary TG
    Infect Dis Clin North Am; 1992 Mar; 6(1):163-76. PubMed ID: 1578115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National reporting of Shiga-like toxin (verotoxin) producing Escherichia coli infections and associated syndromes.
    Commun Dis Intell; 1998 Oct; 22(10):223. PubMed ID: 9803601
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythrocyte P1 group antigen expression in VTEC-associated hemolytic uremic syndrome.
    Ashida A; Matsui K; Chizaki T; Yoshikawa K; Kawamura N; Suzuki K; Tamai H
    Clin Nephrol; 1999 Feb; 51(2):73-6. PubMed ID: 10069641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of verocytotoxin producing capacity and determination of the presence of Shiga-like toxin genes in human Escherichia coli isolates.
    Tóth I; Karcagi V; Nagy B; Gadó I; Milch H
    Acta Microbiol Immunol Hung; 1994; 41(3):259-64. PubMed ID: 7697321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples.
    Law D; Hamour AA; Acheson DW; Panigrahi H; Ganguli LA; Denning DW
    J Med Microbiol; 1994 Apr; 40(4):241-5. PubMed ID: 8151673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic colitis associated with Escherichia coli O157:H7.
    Cohen MB; Giannella RA
    Adv Intern Med; 1992; 37():173-95. PubMed ID: 1557995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infections with verocytotoxin-producing Escherichia coli and hemolytic-uremic syndrome].
    van de Kar NC; Heuvelink AE; de Boer E; Monnens LA
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):134-7. PubMed ID: 8618631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemolytic-uremic syndrome--microbiological study].
    Lhotová H; Bielaszewská M; Kopalová E; Stolbová M
    Cesk Epidemiol Mikrobiol Imunol; 1990 Jan; 39(1):13-20. PubMed ID: 2139808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections with verotoxin-producing Escherichia coli.
    Piérard D
    Acta Clin Belg; 1992; 47(6):387-96. PubMed ID: 1337811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animals as a source of Escherichia coli pathogenic for human beings.
    Whipp SC; Rasmussen MA; Cray WC
    J Am Vet Med Assoc; 1994 Apr; 204(8):1168-75. PubMed ID: 8014086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
    Paton AW; Voss E; Manning PA; Paton JC
    Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.